Health Condition 1: H531- Subjective visual disturbances
Conditions
Interventions
Intervention1: Belladona 6C: Belladona 6C 4 pills once a week followed by placebo 4 pills once a day administered by oral route same repeated for 3 months.
Control Intervention1: Euphrasia 6C: Euphras
Sponsors
Dr. Aditi M Deshmukh
Eligibility
Inclusion criteria
Inclusion criteria: 1 Adults aged 18-40 years of both sexes 2 Participants having eye symptoms because of prolong digital device use having CVS-Q score more than or equal to 6 will only be included irrespective of the use of spectacles 3 Regular digital device users for minimum 5 hours daily for at least 5 days per week
Exclusion criteria
Exclusion criteria: 1 Pre-existing ocular pathology 2 Use of contact lenses 3 History of ocular surgery within the past year 4 Current treatment with lubricating eye drops or other interventions for DES that cannot be discontinued 5 Systemic conditions that may affect tear production 6 Use of medications known to cause dry eyes 7 Pregnancy or breastfeeding 8 Chronic migraine or chronic headache 9 Below 18 and above 40 years of age
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Improved if the CVS-Q score is less than 6 after the treatment 2. Not improved if CVS-Q score is same or more than the pre-treatment scoreTimepoint: CVS-Q score assessed at baseline, 3 months and 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Determine the duration of sustained improvementTimepoint: 6 months | — |
Countries
India
Contacts
Public ContactDr Swati R Shinde
Bharati Vidyapeeth (Deemed To Be University) Homoeopathic Medical College and Hospital, Pune
Outcome results
None listed